A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2006
11/22/2006	CN1864671A Use of 5-hydroxy-1-(4- hydroxyphenyl)-7-phynyl-3-heptanone
11/22/2006	CN1864670A Use of 7-(4- hydroxyphenyl)-1-phynyl-4-alkene-3-heptanone
11/22/2006	CN1864666A Lyophilized powder injection of levofloxacin mesylate and preparation method thereof
11/22/2006	CN1285724C 10-23 desoxyribonuclease of bacillus resisting tubercle branch
11/22/2006	CN1285608C Parainfluenza virus glycoproteins and vaccines
11/22/2006	CN1285606C Nucleotide specific for shigella bodyii 2 O-antigen
11/22/2006	CN1285591C Dimeric compounds and their use as anti-viral agents
11/22/2006	CN1285590C Itraconazole hydrochloride oral solid composition and preparation method
11/22/2006	CN1285586C Tectoridin isoflavone derivatives, their preparation process, and anti-virus medicines with tectoridin isoflavone derivatives as active components
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285379C Process for preparing cold-resistant sugarless Chinese medicine
11/22/2006	CN1285360C Medicine compound having synergistic action
11/22/2006	CN1285356C Ointment against virus of human papilloma
11/22/2006	CN1285350C Chinese medicine for treating cold and its preparing method
11/22/2006	CN1285347C Kuhseng-targeting preparation and its preparing method
11/22/2006	CN1285346C Chinese medicine for treating AIDS
11/22/2006	CN1285345C Compound cactus antivirus preparation
11/21/2006	US7138543 Thiolalkyl benzoic acid derivatives
11/21/2006	US7138531 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138488 Viricides
11/21/2006	US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006	US7138429 Flavonoid compound and process for producing the same
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138410 Aza-bicyclic N-biarylamides with affinity for the α7 nicotinic acetylcholine receptor
11/21/2006	US7138408 Beta-carboline hydroxamic acid derivatives, used to treat AIDS and AIDS-related complex
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138402 Pyrrolopyrimidines and related analogs as HSP90-inhibitors
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	US7138383 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity
11/21/2006	US7138376 Composition for treating a host infected with a hepatitis C viral comprising administering an effective hepatitis C treatment amount of a described 4'-disubstituted nucleoside or a pharmaceutically acceptable salt or prodrug thereof
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138243 NTB-A, a surface molecule involved in natural killer cells activity
11/21/2006	US7138146 Acrochordon alleviation
11/21/2006	US7138138 Pharmaceutical formulation having a masked taste and method for the production thereof
11/21/2006	US7138126 Modifying wild strain of enteroinvasive Shigella; cannot spread within infected cells and from infected to uninfected cells of the host; vaccines; deactivation by inserting transposon into gene; mutagenizing; genetically engineered by allelic exchange
11/21/2006	US7138120 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
11/21/2006	US7138119 Compositions and methods for inhibition of HIV-1 infection
11/21/2006	US7138112 Plasmid maintenance system for antigen delivery
11/21/2006	CA2433386C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/21/2006	CA2275763C Combatting infection in delivery systems
11/21/2006	CA2253736C Antimicrobial treatment for herpes simplex virus and other infectious diseases
11/21/2006	CA2220080C Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form
11/21/2006	CA2187523C Pyranone compounds useful to treat retroviral infections
11/21/2006	CA2154063C Treatment of h. pylori associated gastroduodenal disease
11/16/2006	WO2006122188A2 Tripeptides as hepatitis c virus inhibitors
11/16/2006	WO2006122139A2 Use of tfpi to treat severe bacterial infections
11/16/2006	WO2006122011A2 Thiazole compounds and methods of use
11/16/2006	WO2006121713A2 Delivery of tigecycline in the presence of heparin
11/16/2006	WO2006121507A1 Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria
11/16/2006	WO2006121468A1 5-nitro-nucleoside compounds for treating viral infections
11/16/2006	WO2006121359A1 Epirubicine hydrochloride for treating hepatitis c virus
11/16/2006	WO2006121151A1 Crystal of 1-methylcarbapenem compound
11/16/2006	WO2006120705A2 Treatment and control of severe infections including cystic fibrosis
11/16/2006	WO2006120580A2 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/16/2006	WO2006120576A2 Immunogens for meningitidis-a vaccines
11/16/2006	WO2006120575A2 Tcr-independent activation of t cells with co-lignation of cd28 and cd81
11/16/2006	WO2006120568A2 Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone
11/16/2006	WO2006120567A2 Pharmaceutical composition comprising an anti-bacterial agent and an active ingredient selected from carveol, thymol, eugenol, borneol and carvacrol
11/16/2006	WO2006120565A2 Pharmaceutical combination comprising an antifungal agent and an active substance selected from carveol, eugenol, thymol, borneol, carvacrol and alpha- and beta-ionones
11/16/2006	WO2006120564A1 Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol
11/16/2006	WO2006120496A1 Pharmaceutical combination comprising an antifungal agent and an active substance selected from carveol, eugenol, thymol, borneol and carvacrol
11/16/2006	WO2006120495A1 Pharmaceutical composition comprising an antiviral agent, an antitumour agent or an antiparasitic agent and an active substance selected from carveol, thymol, eugenol, borneol and carvacrol
11/16/2006	WO2006120494A1 Pharmaceutical combination comprising an antibacterial agent and an active substance selected from carveol, thymol, eugenol, borneol and carvacrol
11/16/2006	WO2006120251A1 Pteridines useful as hcv inhibitors and methods for the preparation thereof
11/16/2006	WO2006120160A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases
11/16/2006	WO2006119975A1 Thienopyrroles as antiviral agents
11/16/2006	WO2006119694A1 Quinolinone carboxylic acid derivatives, the preparation and the use thereof
11/16/2006	WO2006119646A1 Compounds and methods for the treatment or prevention of flavivirus infections
11/16/2006	WO2006072624A3 Compositions and methods for treating viral infection
11/16/2006	WO2006050219A3 Broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies
11/16/2006	WO2002094236A9 Delivery of antipsychotics through an inhalation route
11/16/2006	US20060260007 Inhibitors of yeast filamentous growth and method of their manufacture
11/16/2006	US20060259993 Amidases, nucleic acids encoding them and methods for making and using them
11/16/2006	US20060258860 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS
11/16/2006	US20060258848 Human antipneumococcal antibodies from non-human animals
11/16/2006	US20060258839 Cardiovascular disorders; antiinflammatory agents; resemble a G amphipathic helix of apolipoprotein J; phospholipids
11/16/2006	US20060258720 1-Aroyl-2-heteroaryl- or heterocyclyl-4-alkyl-4-pyrrolidinylcarboxylic acids or esters (rel-(2S,4R,5R)-2-Isobutyl-1-(3-methoxy-4-tert-butylbenzoyl)-4-ethoxymethyl-5-(1,3-thiazol-2-yl)pyrrolidine-2-carboxylic acid); antiviral agents; hepatitus C
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258676 Novel crystalline forms of gatifloxacin and processes for preparation
11/16/2006	US20060258675 Novel crystalline forms of gatofloxacin and processes for preparation
11/16/2006	US20060258674 Novel crystalline forms of gatifloxacin and processes for preparation
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006	US20060258591 Compositions and methods of treating HIV infections
11/16/2006	US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006	US20060258571 Antibacterial ester macrocycles
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257981 culturing a microorganism belonging to the species Dactylosporangium, in a nutrient medium and isolating tiacumicin B; antibiotics used for prophylaxis and therapy of bacterial infections
11/16/2006	US20060257940 Transformed Shigella
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257872 Cell lines and host nucleic acid sequences related to infectious disease
11/16/2006	US20060257865 Method for identification and development of therapeutic agents
11/16/2006	US20060257850 Methods of treatment and diagnosis of patients with hepatitis c infection
11/16/2006	US20060257432 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucelic acid replication

1 ... 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 ... 1798